Progress in HER2-Positive Gastroesophageal Adenocarcinoma
(MedPage Today) -- After a period of relative inactivity, therapeutic development in HER2-positive gastroesophageal adenocarcinoma (GEA) has evolved rapidly over the past 5 years, establishing a new standard of care that was supplanted by another...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.